Literature DB >> 17183612

FOXP3: not just for regulatory T cells anymore.

Steven F Ziegler1.   

Abstract

The forkhead family transcription factor FOXP3 has been shown to be critical for the development and function of CD4+ CD25+ regulatory T cells. Recently, FOXP3 expression has been shown to be induced upon activation of human CD4+ T cells. A new report in this issue of the European Journal of Immunology shows that expression of FOXP3 in activated T cell leads to hyporesponsiveness, but not necessarily to acquisition of suppressor function. This finding suggests a new role for FOXP3 in human CD4+ T cells: down-modulating responses to TCR-mediated stimulation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17183612     DOI: 10.1002/eji.200636929

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  53 in total

Review 1.  The biology of FoxP3: a key player in immune suppression during infections, autoimmune diseases and cancer.

Authors:  Frances Mercer; Derya Unutmaz
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

2.  CD4+ CD25+ but not CD4+ Foxp3+ T cells as a regulatory subset in primary biliary cirrhosis.

Authors:  Dandan Wang; Huayong Zhang; Jun Liang; Zhifeng Gu; Qiang Zhou; Xiangshan Fan; Yayi Hou; Lingyun Sun
Journal:  Cell Mol Immunol       Date:  2010-08-23       Impact factor: 11.530

Review 3.  Immune Evasion by Head and Neck Cancer: Foundations for Combination Therapy.

Authors:  Joshua D Horton; Hannah M Knochelmann; Terry A Day; Chrystal M Paulos; David M Neskey
Journal:  Trends Cancer       Date:  2019-03-20

Review 4.  Induced regulatory T cells: mechanisms of conversion and suppressive potential.

Authors:  Eefje M Dons; Giorgio Raimondi; David K C Cooper; Angus W Thomson
Journal:  Hum Immunol       Date:  2012-01-14       Impact factor: 2.850

Review 5.  Special regulatory T-cell review: FOXP3 biochemistry in regulatory T cells--how diverse signals regulate suppression.

Authors:  Bin Li; Mark I Greene
Journal:  Immunology       Date:  2008-01       Impact factor: 7.397

6.  Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity.

Authors:  Noriko Komatsu; Maria Encarnita Mariotti-Ferrandiz; Ying Wang; Bernard Malissen; Herman Waldmann; Shohei Hori
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-27       Impact factor: 11.205

7.  Characteristics of CD4+CD25+Foxp3+ regulatory T cells in patients with multiple organ dysfunction syndrome.

Authors:  Xiuxian Zang; Yanfang Jiang; Xiujiang Li; Yujun DU; Junqi Niu
Journal:  Exp Ther Med       Date:  2016-03-15       Impact factor: 2.447

8.  Immunologic reconstitution during PEG-ADA therapy in an unusual mosaic ADA deficient patient.

Authors:  Ping Liu; Ines Santisteban; Lauri M Burroughs; Hans D Ochs; Troy R Torgerson; Michael S Hershfield; David J Rawlings; Andrew M Scharenberg
Journal:  Clin Immunol       Date:  2008-10-25       Impact factor: 3.969

9.  Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors.

Authors:  Katy Milne; Martin Köbel; Steven E Kalloger; Rebecca O Barnes; Dongxia Gao; C Blake Gilks; Peter H Watson; Brad H Nelson
Journal:  PLoS One       Date:  2009-07-29       Impact factor: 3.240

10.  Expression and function of TNF and IL-1 receptors on human regulatory T cells.

Authors:  Frances Mercer; Lina Kozhaya; Derya Unutmaz
Journal:  PLoS One       Date:  2010-01-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.